|
1
|
Dennis LK, Lynch CF and Torner JC:
Epidemiologic association between prostatitis and prostate cancer.
Urology. 60:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang J, Li J, Yunxia Z, Zhu H, Liu J and
Pumill C: The role of prostatitis in prostate cancer:
Meta-analysis. PLoS One. 8:e851792013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gerstenbluth RE, Seftel AD, MacLennan GT,
Rao RN, Corty EW, Ferguson K and Resnick MI: Distribution of
chronic prostatitis in radical prostatectomy specimens with
up-regulation of bcl-2 in areas of inflammation. J Urol.
167:2267–2270. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Irani J, Goujon JM, Ragni E, Peyrat L,
Hubert J, Saint F and Mottet N: Pathologist Multi Center Study
Group: High-grade inflammation in prostate cancer as a prognostic
factor for biochemical recurrence after radical prostatectomy.
Urology. 54:467–472. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Engelhardt PF, Brustmann H, Seklehner S
and Riedl CR: Chronic asymptomatic inflammation of the prostate
type IV and carcinoma of the prostate: Is there a correlation?
Scand J Urol. 47:230–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karakiewicz PI, Benayoun S, Bégin LR,
Duclos A, Valiquette L, McCormack M, Bénard F, Saad F and Perrotte
P: Chronic inflammation is negatively associated with prostate
cancer and high-grade prostatic intraepithelial neoplasia on needle
biopsy. Int J Clin Pract. 61:425–430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moreira DM, Nickel JC, Gerber L, Muller
RL, Andriole GL, Castro-Santamaria R and Freedland SJ: Baseline
prostate inflammation is associated with a reduced risk of prostate
cancer in men undergoing repeat prostate biopsy: Results from the
REDUCE study. Cancer. 120:190–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Porcaro AB, Rubilotta E, Petrozziello A,
Ghimenton C, Migliorini F, Antoniolli Zecchini S, Lacola V, Monaco
C, Curti P, Cavalleri S, et al: Chronic inflammation of the
prostate type IV with respect to risk of prostate cancer. Arch Ital
Urol Androl. 86:208–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roberts RO, Bergstralh EJ, Bass SE, Lieber
MM and Jacobsen SJ: Prostatitis as a risk factor for prostate
cancer. Epidemiology. 15:93–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
WMA Declaration of Helsinki - Ethical
Principles for Medical Research Involving Human Subjects.
https://www.wma.net/en/30publications/10policies/b3/Accessed.
Apr 15–2016
|
|
11
|
Mehik A, Hellström P, Lukkarinen O,
Sarpola A and Järvelin M: Epidemiology of prostatitis in Finnish
men: A population-based cross-sectional study. BJU Int. 86:443–448.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Statistics Finland. https://www.tilastokeskus.fi/index_en.htmlAccessed. Apr
15–2016
|
|
13
|
Collins MM, Meigs JB, Barry MJ, Corkery
Walker E, Giovannucci E and Kawachi I: Prevalence and correlates of
prostatitis in the health professionals follow-up study cohort. J
Urol. 167:1363–1366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sobin L and Wittekind C: Union for
International Cancer Control: TNM Classification of Malignant
Tumours (6th). Wiley. New York: 2002.
|
|
15
|
Daniels NA, Ewing SK, Zmuda JM, Wilt TJ
and Bauer DC: Osteoporotic Fractures in Men (MrOS) Research Group:
Correlates and prevalence of prostatitis in a large community-based
cohort of older men. Urology. 66:964–970. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edlin RS, Heyns CF, Van Vuuren SP and
Zarrabi AD: Prevalence of histological prostatitis in men with
benign prostatic hyperplasia or adenocarcinoma of the prostate
presenting without urinary retention. S Afr J Surg. 50:127–130.
2012.PubMed/NCBI
|
|
17
|
Nickel JC, Roehrborn CG, O'leary MP,
Bostwick DG, Somerville MC and Rittmaster RS: Examination of the
relationship between symptoms of prostatitis and histological
inflammation: Baseline data from the REDUCE chemoprevention trial.
J Urol. 178:896–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weight CJ, Kim SP, Jacobson DJ, McGree ME,
Boorjian SA, Thompson RH, Leibovich BC, Karnes RJ and St Sauver J:
The effect of benign lower urinary tract symptoms on subsequent
prostate cancer testing and diagnosis. Eur Urol. 63:1021–1027.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu K, McKnight B, Stergachis A, Daling JR
and Levine RS: Comparison of self-report data and medical records
data: Results from a case-control study on prostate cancer. Int J
Epidemiol. 28:409–417. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Finnish Cancer Registry - Legislation.
https://www.cancer.fi/syoparekisteri/en/general/legislation/Accessed.
Apr 15–2016
|
|
21
|
Teppo L, Pukkala E and Lehtonen M: Data
quality and quality control of a population-based cancer registry.
Experience in Finland. Acta Oncol. 33:365–369. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krieger JN, Egan KJ, Ross SO, Jacobs R and
Berger RE: Chronic pelvic pains represent the most prominent
urogenital symptoms of ‘chronic prostatitis’. Urology. 48:715–722.
1996. View Article : Google Scholar : PubMed/NCBI
|
